ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer

November 29, 2002

NCI Largely Unaffected By NIH Translational Research Center

February 11, 2011

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

Obituary: Gregory Foltz, Swedish Medical Center Neurosurgeon

July 12, 2013

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

March 28, 2008

NCI Asks $135 Billion for FY 1981, Tells How New Money Would Be Spent

June 1, 1979